Catalyst Wire Dossier Catalyst Wire Dossier

NUMBRINO

COCAINE HYDROCHLORIDE NASAL · OMNIVIUM PHARMACEUTICALS LLC.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NUMBRINO, covering 2020-01-10 to 2020-08-27. Get the full timeline:

Most recent: FDA Approved: NUMBRINO — Supplemental Application (OMNIVIUM PHARMACEUTICALS LLC.)

See pricing